HF
SEEL

HRT Financial’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

HRT Financial’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-23
Closed -$59K – 3668
2022
Q2 		$59K Buy
+23
New +$59.9K ﹤0.01% 2498
2022
Q1 		– Sell
-4
Closed -$24K – 4042
2021
Q4 		$24K Buy
+4
New +$30.7K ﹤0.01% 2928

Other funds holding SEEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

HRT Financial's SEEL Position: Q3 2022 in Review

HRT Financial sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2022, closing a stake of 23 shares — an estimated $59K sold.

HRT Financial first reported a position in SEEL in Q4 2021 and held it in 2 quarters. The position peaked at $59K in Q2 2022. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.

  • HRT Financial reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 23 Seelos Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $59K.
  • HRT Financial first reported a position in Seelos Therapeutics, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • HRT Financial's Seelos Therapeutics, Inc. Common Stock position peaked at $59K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.